OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidemiology of haematological malignancies in people living with HIV
Stephen Kimani, Matthew Painschab, Marie‐Josèphe Horner, et al.
The Lancet HIV (2020) Vol. 7, Iss. 9, pp. e641-e651
Open Access | Times Cited: 72
Stephen Kimani, Matthew Painschab, Marie‐Josèphe Horner, et al.
The Lancet HIV (2020) Vol. 7, Iss. 9, pp. e641-e651
Open Access | Times Cited: 72
Showing 1-25 of 72 citing articles:
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 114
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 114
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 12
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 12
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, et al.
Blood Advances (2021) Vol. 5, Iss. 14, pp. 2852-2862
Open Access | Times Cited: 45
Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, et al.
Blood Advances (2021) Vol. 5, Iss. 14, pp. 2852-2862
Open Access | Times Cited: 45
Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies
Chaoyu Wang, Jun Li, Yao Liu
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 27
Chaoyu Wang, Jun Li, Yao Liu
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 27
Diffuse Large B-Cell Lymphoma in the HIV Setting
María Luisa López Huguet, José‐Tomás Navarro, José Moltó, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3191-3191
Open Access | Times Cited: 16
María Luisa López Huguet, José‐Tomás Navarro, José Moltó, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3191-3191
Open Access | Times Cited: 16
Enabling CAR T ‐cell therapies for HIV ‐positive lymphoma patients – A call for action
Tessa Hattenhauer, Rebekka Mispelbaum, Marcus Hentrich, et al.
HIV Medicine (2023) Vol. 24, Iss. 9, pp. 957-964
Open Access | Times Cited: 14
Tessa Hattenhauer, Rebekka Mispelbaum, Marcus Hentrich, et al.
HIV Medicine (2023) Vol. 24, Iss. 9, pp. 957-964
Open Access | Times Cited: 14
Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
Juanjuan Chen, Yihua Wu, Han Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Juanjuan Chen, Yihua Wu, Han Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort study
Marriam Mponda, Evaristar Kudowa, Dalton M. Craven, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102480-102480
Open Access | Times Cited: 5
Marriam Mponda, Evaristar Kudowa, Dalton M. Craven, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102480-102480
Open Access | Times Cited: 5
Global, regional, and national burden of Burkitt lymphoma from 1990 to 2021 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2021
Ying Wang, Ziyuan Shen, Chenlu He, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Ying Wang, Ziyuan Shen, Chenlu He, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies
Blake J. Rust, Hans‐Peter Kiem, Thomas S. Uldrick
The Lancet Haematology (2020) Vol. 7, Iss. 9, pp. e690-e696
Closed Access | Times Cited: 29
Blake J. Rust, Hans‐Peter Kiem, Thomas S. Uldrick
The Lancet Haematology (2020) Vol. 7, Iss. 9, pp. e690-e696
Closed Access | Times Cited: 29
Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report
Toshali Pandey, Sumant Inamdar, Susanne K. Jeffus, et al.
Cureus (2025)
Open Access
Toshali Pandey, Sumant Inamdar, Susanne K. Jeffus, et al.
Cureus (2025)
Open Access
Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
Stephen Kimani, Matthew Painschab, Bongani Kaimila, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 7, pp. e1008-e1016
Open Access | Times Cited: 23
Stephen Kimani, Matthew Painschab, Bongani Kaimila, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 7, pp. e1008-e1016
Open Access | Times Cited: 23
Hodgkin Lymphoma in People Living with HIV
José‐Tomás Navarro, José Moltó, Gustavo Tapia, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4366-4366
Open Access | Times Cited: 22
José‐Tomás Navarro, José Moltó, Gustavo Tapia, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4366-4366
Open Access | Times Cited: 22
Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management
Antonino Carbone, Amy Chadburn, Annunziata Gloghini, et al.
Blood Reviews (2024) Vol. 64, pp. 101167-101167
Closed Access | Times Cited: 3
Antonino Carbone, Amy Chadburn, Annunziata Gloghini, et al.
Blood Reviews (2024) Vol. 64, pp. 101167-101167
Closed Access | Times Cited: 3
Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches
Mihaela Straistă, Francesca Caccuri, Nicoleta Arnaut, et al.
Cells (2025) Vol. 14, Iss. 10, pp. 705-705
Open Access
Mihaela Straistă, Francesca Caccuri, Nicoleta Arnaut, et al.
Cells (2025) Vol. 14, Iss. 10, pp. 705-705
Open Access
Human Immunodeficiency Virus Related Non-Hodgkin’s Lymphoma
Tesfaye Gessese, Fikir Asrie, Zewudu Mulatie
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 13-24
Open Access | Times Cited: 8
Tesfaye Gessese, Fikir Asrie, Zewudu Mulatie
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 13-24
Open Access | Times Cited: 8
Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease
Carolina Caro‐Vegas, Alice Peng, Angelica Juarez, et al.
JCI Insight (2023) Vol. 8, Iss. 22
Open Access | Times Cited: 8
Carolina Caro‐Vegas, Alice Peng, Angelica Juarez, et al.
JCI Insight (2023) Vol. 8, Iss. 22
Open Access | Times Cited: 8
How can we establish animal models of HIV‐associated lymphoma?
Qing Xiao, Liuyue Zhai, Xiaomei Zhang, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 4, pp. 484-496
Open Access | Times Cited: 2
Qing Xiao, Liuyue Zhai, Xiaomei Zhang, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 4, pp. 484-496
Open Access | Times Cited: 2
Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants
Rosemary Rochford
Annals of Lymphoma (2021) Vol. 5, pp. 22-22
Open Access | Times Cited: 16
Rosemary Rochford
Annals of Lymphoma (2021) Vol. 5, pp. 22-22
Open Access | Times Cited: 16
Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis
Matthew Painschab, Racquel E. Kohler, Stephen Kimani, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 9, pp. e1305-e1313
Open Access | Times Cited: 15
Matthew Painschab, Racquel E. Kohler, Stephen Kimani, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 9, pp. e1305-e1313
Open Access | Times Cited: 15
Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study
Yann Ruffieux, Tafadzwa Dhokotera, Mazvita Muchengeti, et al.
The Lancet HIV (2021) Vol. 8, Iss. 10, pp. e614-e622
Open Access | Times Cited: 15
Yann Ruffieux, Tafadzwa Dhokotera, Mazvita Muchengeti, et al.
The Lancet HIV (2021) Vol. 8, Iss. 10, pp. e614-e622
Open Access | Times Cited: 15
Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance
Kenneth J C Lim, Pietro R Di Ciaccio, Mark N. Polizzotto, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 5, pp. 865-873
Closed Access | Times Cited: 6
Kenneth J C Lim, Pietro R Di Ciaccio, Mark N. Polizzotto, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 5, pp. 865-873
Closed Access | Times Cited: 6
Autologous Stem Cell Transplantation in HIVPositive and HIV-Negative Patients with Lymphoma: A Propensity Score Matched Comparative Analysis
Alessandro Re, Margherita Oberti, Armando Stabile, et al.
(2024)
Open Access | Times Cited: 2
Alessandro Re, Margherita Oberti, Armando Stabile, et al.
(2024)
Open Access | Times Cited: 2
Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Kai Hübel, Mark Bower, Igor Aurer, et al.
Annals of Oncology (2024) Vol. 35, Iss. 10, pp. 840-859
Open Access | Times Cited: 2
Kai Hübel, Mark Bower, Igor Aurer, et al.
Annals of Oncology (2024) Vol. 35, Iss. 10, pp. 840-859
Open Access | Times Cited: 2
Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up
Kai Hübel, Mark Bower, Igor Aurer, et al.
HemaSphere (2024) Vol. 8, Iss. 9
Open Access | Times Cited: 2
Kai Hübel, Mark Bower, Igor Aurer, et al.
HemaSphere (2024) Vol. 8, Iss. 9
Open Access | Times Cited: 2
